Good afternoon, and welcome to the Health Brief newsletter. Our brilliant regular Health Brief writer Megan Wilson is getting ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...

The company reaffirmed its full-year 2026 revenue guidance of $2.3 to $2.6 billion and maintained a strong cash position of ...

As state leaders change laws to make vaccines more accessible, a coalition of doctors, public health advocates and everyday ...

Those who cheered ivermectin as a Covid-19 treatment, like Marjorie Taylor Greene, are now making unsubstantiated claims ...

The CDC has issued its updated 2026 adult immunization schedule, adding refined RSV vaccine eligibility, annual COVID-19 boosters, and clarified pneumococcal options. The changes aim to simplify ...

The CDC’s 2026 adult immunization schedule adds earlier shingles vaccination, widens RSV vaccine eligibility, and adopts an annual COVID-19 booster model. These updates respond to shifting disease ...

This is read by an automated voice. Please report any issues or inconsistencies here. A highly mutated COVID-19 strain is circulating in California — raising concerns that disease activity could rise ...

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and combination strategy highlighted through multiple clinical ...

The Pentagon said the Iran war cost $25 billion for roughly two months of spending. Battle damage could net much more.

More than a year later, the FDA has not introduced any of the detailed, scientific regulatory documents needed to establish a ...

NHS issues Covid jab warning over ‘waning immunity’ – how to get yours - NHS England said these patients will be invited to come forward for their spring Covid-19 vaccinations ...